Structured evidence table for Elderflower Immune Support Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Elderflower Immune Support Randomized Trial | No clinically significant changes were found in the safety test of vital signs, blood and urine biomarkers, and adverse events. | 2 | Seo JW (2025) | Safety and Tolerability of HemoHIM: A Randomized, Placebo-Controlled, Double-Blind, and Parallel Clinical Trial in Healthy Human Volunteers. |
| Elderflower Immune Support Randomized Trial | Despite many studies on HemoHIM's antioxidant properties and its effect on immune functions, fatigue reduction, and exercise performance, published data regarding its physiological safety in humans are lacking. | 2 | Seo JW (2025) | Safety and Tolerability of HemoHIM: A Randomized, Placebo-Controlled, Double-Blind, and Parallel Clinical Trial in Healthy Human Volunteers. |
| Elderflower Immune Support Randomized Trial | Therefore, this study aimed to investigate the safety profile of HemoHIM in humans. | 2 | Seo JW (2025) | Safety and Tolerability of HemoHIM: A Randomized, Placebo-Controlled, Double-Blind, and Parallel Clinical Trial in Healthy Human Volunteers. |
| Elderflower Immune Support Randomized Trial | Although mild upper respiratory tract infections (MURTIs) are typically self-limiting and benign, they can substantially impair a patient's quality of life. | 4 | Smith A (2025) | Holistic care in mild upper respiratory tract infections (MURTIs): an approach to individualized care management. |
| Elderflower Immune Support Randomized Trial | The wide range of pathogens causing MURTIs often necessitates a symptomatic treatment approach rather than a pathogen-specific treatment. | 4 | Smith A (2025) | Holistic care in mild upper respiratory tract infections (MURTIs): an approach to individualized care management. |
Source documents